Medical specialists from France tagged as investigators in clinical trials studying Adenomyoepithelioma
Total 7 results
-
Antoine ItalianoSeen in:
- Aquitaine, Bordeaux, Institut Bergonié - Centre Régional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest
- Bordeaux Cedex, Institut Bergonie
- Bordeaux, Bergonie Institute
- Bordeaux, Institut Bergonie
- Bordeaux, Institut Bergonié - Centre Régional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest
Trials:- NCT05009927 (Principal Investigator)
- NCT03906331 (Principal Investigator)
- NCT05440786 (Principal Investigator)
- NCT05269355 (Principal Investigator)
- NCT02834884 (Principal Investigator)
- NCT03157128 (Principal Investigator)
- NCT02029001 (Principal Investigator)
- NCT04104776 (Principal Investigator)
- NCT05920408 (Principal Investigator)
- NCT05999994 (Principal Investigator)
Conditions:- C-KIT Mutation;
- Metastatic Gastrointestinal Stromal Tumor (GIST);
- Advanced Gastrointestinal Stromal Tumor (GIST);
- Breast Cancer;
- Pancreatic Cancer;
- Non Small Cell Lung Cancer;
- Colon Cancer;
- Medullary Thyroid Cancer;
- Papillary Thyroid Cancer;
- Other Solid Tumors With Evidence of Activating RET Alteration;
- Neoplasm Metastasis;
- Sarcoma, Ewing;
- Leiomyosarcoma;
- All Tumor Types;
- Non-Small Cell Lung Cancer;
- Any Solid Tumor;
- Malignant Solid Neoplasms;
- Lymphoma, T-Cell;
- Mesothelioma, Malignant;
- Advanced Solid Tumor;
- Endometrial Cancer;
- Diffuse Large B Cell Lymphoma;
- Ovarian Clear Cell Carcinoma;
- Prostatic Neoplasms, Castration-Resistant;
- Advanced Solid Tumours;
- Adolescent;
- Neoplasms;
- Child
-
Cyril AbdeddaimSeen in:
- Lille, Centre OSCAR LAMBRET
- Lille, Oscar Lambret Center
Trials:- NCT03088059 (Principal Investigator)
- NCT04104776 (Principal Investigator)
-
Lauriane EberstSeen in:
- Strasbourg, Strasbourg Europe Institut of Cancerology
Trials:- NCT04104776 (Principal Investigator)
-
Mehdi BrahmiSeen in:
- Lyon, Centre Léon Berard
- Lyon, Leon Berard Center
- Rhone, Lyon cedex 08, Centre Léon Berard
Trials:- NCT04104776 (Principal Investigator)
- NCT04927260 (Principal Investigator)
- NCT04936178 (Principal Investigator)
-
Thomas GastinneSeen in:
- Loire-Atlantique, Nantes, CHU de Nantes - Hematologie
- Loire-Atlantique, Nantes, CHU de Nantes - Service d'Hématologie Clinique Place Alexis Ricordeau
- Loire-Atlantique, Nantes, Service d'Hématologie Clinique Place Alexis Ricordeau
- Nantes Cedex 1, Centre Hospitalier Universitaire de Nantes - L' Hopital l'hôtel-Dieu
- Nantes, CHU Nantes
- Nantes, Hospital North
- Nantes, Nantes University Hospital Center - Hotel Dieu Hospital
- Nantes, Nantes University Hospital Center - Hotel Dieu Hospital (Satellite)
- Other, Nantes cedex 1, Centre Hospitalier Universitaire Nantes-Hotel Dieu
Trials:- NCT04662255 (Principal Investigator)
- NCT04404283 (Principal Investigator)
- NCT04104776 (Principal Investigator)
- NCT04224493 (Principal Investigator)
- NCT04446962 (Principal Investigator)
Conditions:- Lymphoma, Mantle-Cell;
- Diffuse Large B-cell Lymphoma;
- Lymphoma, T-Cell;
- Mesothelioma, Malignant;
- Advanced Solid Tumor;
- Endometrial Cancer;
- Diffuse Large B Cell Lymphoma;
- Ovarian Clear Cell Carcinoma;
- Prostatic Neoplasms, Castration-Resistant;
- Follicular Lymphoma;
- Relapsed/Refractory Follicular Lymphoma;
- Refractory Follicular Lymphoma;
- Lymphoma, Large B-Cell, Diffuse;
- Central Nervous System Neoplasms, Primary
-
Vincent Ribrag, MDSeen in:
- Val De Marne, Villejuif cedex, Institut Gustave Roussy
- Villejuif, Gustave Roussy
Trials:- NCT05176691 (Principal Investigator)
- NCT04104776 (Principal Investigator)
Conditions:- Follicular Lymphoma;
- Waldenstrom Macroglobulinemia;
- Lymphoplasmacytic Lymphoma;
- NHL;
- DLBCL;
- Richter Syndrome;
- CLL/SLL;
- MCL;
- MZL;
- Lymphoma, T-Cell;
- Mesothelioma, Malignant;
- Advanced Solid Tumor;
- Endometrial Cancer;
- Diffuse Large B Cell Lymphoma;
- Ovarian Clear Cell Carcinoma;
- Prostatic Neoplasms, Castration-Resistant
Clinical Trials on Adenomyoepithelioma
-
University Health Network, TorontoCompleted
-
Peking University Third HospitalNot yet recruitingOvarian Clear Cell Carcinoma
-
M.D. Anderson Cancer CenterGSK Pharma; LixteRecruitingOvarian Clear Cell CarcinomaUnited States
-
M.D. Anderson Cancer CenterRecruitingHuman Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-TypeUnited States
-
National University Hospital, SingaporeUnknownOvarian Clear Cell CarcinomaSingapore
-
Tongji HospitalWuhan University; Henan Cancer Hospital; Qilu Hospital of Shandong University; Hubei... and other collaboratorsRecruitingOvarian Clear Cell CarcinomaChina
-
National Taiwan University HospitalSamsung Medical Center; Chang Gung Memorial Hospital; Tokyo UniversityNot yet recruitingFIGO Stage IC2 to II Ovarian Clear Cell Carcinoma
-
Elizabeth K. Lee MDMerck Sharp & Dohme LLCRecruitingGynecologic Cancer | Ovarian Clear Cell CarcinomaUnited States
-
Haihe Biopharma Co., Ltd.RecruitingOvarian Cancer | Recurrent CancerChina, Japan
-
TScan Therapeutics, Inc.Washington University School of MedicineWithdrawnRenal Clear Cell CarcinomaUnited States